middle.news
Bubs Advances US Market Bid with Landmark Infant Formula Submission
8:39am on Monday 16th of June, 2025 AEST
•
Consumer Staples
Read Story
Bubs Advances US Market Bid with Landmark Infant Formula Submission
8:39am on Monday 16th of June, 2025 AEST
Key Points
Submission of New Infant Formula Submission (NIFS) to US FDA
Completion of largest-ever US infant formula clinical trial with 478 infants
Bubs among only eight companies under FDA’s Enforcement Discretion process
Permanent US market access expected by end of 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bubs Australia (ASX:BUB)
OPEN ARTICLE